Michael Gale, Jr.
About Michael Gale, Jr.
Michael Gale Jr. - Scientific Co-Founder and Immunology Professor
Michael Gale Jr. holds the position of Scientific Co-Founder and serves as a Professor of Immunology. His extensive expertise in the field is reflected through his involvement in various roles that delve into the study of virus and host interactions. As a Professor, he imparts invaluable knowledge in virology, immunology, infectious disease biology, and public health to his students, fostering the next generation of experts in these critical fields.
Director of the UW Center for Innate Immunity and Immune Disease (CIIID)
Michael Gale Jr. leads the UW Center for Innate Immunity and Immune Disease (CIIID) as its Director. The CIIID is dedicated to understanding the fundamental mechanisms of the immune system and its response to pathogenic RNA viruses. Under Gale’s leadership, the center conducts pivotal research that aims to uncover therapeutic targets to enhance immune responses and control infections. His lab, which is an integral part of CIIID, specializes in the innate immunity to RNA virus infections, contributing significantly to the center’s mission.
Core Staff of the Infectious Disease and Translational Medicine Division
Michael Gale Jr. is a core staff member of the Infectious Disease and Translational Medicine Division at the Washington National Primate Research Center. In this capacity, he works closely on translational medicine projects aimed at bridging the gap between laboratory research and clinical applications. His collaborative efforts contribute to advancing knowledge in infectious diseases, which is vital for developing new therapies and treatment strategies.
Associate Director of the UW Center for Emerging and Re-emerging Infectious Disease (CERID)
As the Associate Director of the UW Center for Emerging and Re-emerging Infectious Disease (CERID), Michael Gale Jr. plays a pivotal role in guiding research efforts focused on combating infectious diseases that pose significant public health challenges. CERID's research spans various viral pathogens, including SARS-CoV-2, flaviviruses like West Nile, dengue, Zika, and hepatitis C, among others. Gale’s leadership helps steer the center’s initiatives to better understand and mitigate the impacts of these infectious agents.
Research Program on Virus and Host Interactions in Innate Immunity
Michael Gale Jr. leads a comprehensive research program concentrating on virus and host interactions within innate immunity. His studies encompass a range of significant viruses including SARS-CoV-2, hepatitis B, hepatitis C, influenza A, hanta virus, Ebola, and various coronaviruses. The primary focus of his research is to identify therapeutic targets that can enhance immune responses and control infections by pathogenic RNA viruses. Additionally, Gale’s work involves defining immune gene signatures and mechanisms of protection in SIV/HIV vaccine clinical trials, contributing to the development of effective vaccines.
Editorial Board Member of Biomedical Research Journals
Michael Gale Jr. serves on the editorial boards of multiple biomedical research journals. In this role, he contributes his expertise to oversee the review process, ensuring the publication of high-quality research findings in the field of immunology and infectious diseases. His commitment to scientific rigor and excellence helps advance the body of knowledge in these crucial areas.